Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Cools

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Blood|July 20, 2023
Targeting STAT5B in T-cell acute lymphoblastic leukemiaAlexandra Veloso, Jan Cools
Expert Review of Anticancer Therapy|September 19, 2009
Recent breakthroughs in the understanding and management of chronic eosinophilic leukemiaEls Lierman, Jan Cools
Haematologica|December 10, 2009
New flow cytometry in hematologic malignanciesJan Cools, Peter Vandenberghe
Hemasphere|June 7, 2021
The Fifth Year of <i>HemaSphere</i>Jan Cools, Andreas Engert
Nature Genetics|October 29, 2015
The genomic landscape of adult T cell leukemia/lymphomaCarmen Vicente, Jan Cools
Haematologica|November 2, 2015
The origin of relapse in pediatric T-cell acute lymphoblastic leukemiaCarmen Vicente, Jan Cools
Immunology and Allergy Clinics of North America|September 18, 2007
Novel approaches to therapy of hypereosinophilic syndromesHans-Uwe Simon, Jan Cools
Nature Cancer|May 30, 2024
Selective targeting of malignant T cellsCharles E de Bock, Jan Cools
Cancer Cell|June 10, 2015
T-ALL: Home Is where the CXCL12 IsCharles E de Bock, Jan Cools
Blood|November 11, 2021
BETter insight into PRC2-mutated T-ALLCharles E de Bock, Jan Cools
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Blood|July 20, 2023
Targeting STAT5B in T-cell acute lymphoblastic leukemiaAlexandra Veloso, Jan Cools
Expert Review of Anticancer Therapy|September 19, 2009
Recent breakthroughs in the understanding and management of chronic eosinophilic leukemiaEls Lierman, Jan Cools
Haematologica|December 10, 2009
New flow cytometry in hematologic malignanciesJan Cools, Peter Vandenberghe
Hemasphere|June 7, 2021
The Fifth Year of <i>HemaSphere</i>Jan Cools, Andreas Engert
Nature Genetics|October 29, 2015
The genomic landscape of adult T cell leukemia/lymphomaCarmen Vicente, Jan Cools
Haematologica|November 2, 2015
The origin of relapse in pediatric T-cell acute lymphoblastic leukemiaCarmen Vicente, Jan Cools
Immunology and Allergy Clinics of North America|September 18, 2007
Novel approaches to therapy of hypereosinophilic syndromesHans-Uwe Simon, Jan Cools
Nature Cancer|May 30, 2024
Selective targeting of malignant T cellsCharles E de Bock, Jan Cools
Cancer Cell|June 10, 2015
T-ALL: Home Is where the CXCL12 IsCharles E de Bock, Jan Cools
Blood|November 11, 2021
BETter insight into PRC2-mutated T-ALLCharles E de Bock, Jan Cools
Pageof 19